In humans, the expression of linear ANRIL isoforms has been correlated with more severe cardiac disease outcomes, while the circular ANRIL has been associated with a protective phenotype, like a decrease in oxidative stress (Rodríguez‐Esparragón et al., 2023). This evidence concerns the gene CDKN2B-AS1 and heart disorder.